Eur Rev Med Pharmacol Sci 2023; 27 (7): 3191-3200
DOI: 10.26355/eurrev_202304_31953

COVID-19 and bone health

C.-L. Hu, M.-J. Zheng, X.-X. He, D.-C. Liu, Z.-Q. Jin, W.-H. Xu, P.-Y. Lin, J.-W. Cheng, Q.-G. Wei

Department of Trauma Orthopedic and Hand Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, China. weiqingjungxnn@163.com


A few patients who have recovered from COVID-19 develop persistent or new symptoms that last for weeks or months; this is called “long COVID” or “post-COVID-19 syndrome.” Over time, awareness of the short- and long-term consequences of COVID-19 has increased. The pulmonary consequences are now fairly well established, but little is known about the extrapulmonary system of COVID-19, particularly its effects on bones. Current evidence and reports indicate a direct relationship between SARS-CoV-2 infection and bone health, with SARS-CoV-2 having a significant negative effect on bone health. In this review, we analyzed the impact of SARS-CoV-2 infection on bone health and assessed the impact of COVID-19 on the diagnosis and treatment of osteoporosis.

Free PDF Download

To cite this article

C.-L. Hu, M.-J. Zheng, X.-X. He, D.-C. Liu, Z.-Q. Jin, W.-H. Xu, P.-Y. Lin, J.-W. Cheng, Q.-G. Wei
COVID-19 and bone health

Eur Rev Med Pharmacol Sci
Year: 2023
Vol. 27 - N. 7
Pages: 3191-3200
DOI: 10.26355/eurrev_202304_31953